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Abstract
Introduction: Pure primary squamous cell carcinoma of the breast is uncommon and it’s debated
the correct management of this disease.
Case presentation: A54-years-oldwomanpresentedwithsignsandsymptomsofmastitisofleftbreast.
Apalpablewellcircumscribedandfirmmass,measuringabout40mm,waspresentintheleftlowerlateral
quadrant. She underwent antibiotic therapy without benefit. She performed an ultrasound and
mammographic scan of the left breast. Fine needle aspiration cytology revealed an infiltrative poorly
differentiated squamous cell carcinoma. Total body CT scan and bone scan excluded distant metastasis.
Subsequently wide local excision of the left breast with ipsilateral axillary lymph nodes dissection was
performed. The pathological examination revealed an infiltrative poorly differentiated squamous cell
carcinoma of the breast. Adjuvant chemotherapy cisplatin and 5-fluorouracil based was administered.
Patientrefusedlocoregionalradiotherapy.Twenty-eightmonthsaftersurgerythepatientwasdiseasefree.
Conclusions: Pure primary squamous cell carcinoma of the breast is a rare and aggressive disease
often treatment-refractory. An optimal systemic treatment is needed to improve patient’s outcome.
Introduction
Pure primary squamous cell carcinoma of the breast is a
relatively uncommon desease. It is diagnosed if more than
90 % of the malignant cells are squamous. It represents
less than 0.1 % of all breast carcinomas [1].
The prognosis of this type of breast cancer is still a subject
of controversy; some reports suggest that it is aggressive,
with an outcome comparable to poorly differentiated
ductal carcinoma of the breast [2-5].
Clinical and radiologic appearances are not specific to
discriminate malignant versus benign lesions or to
characterize the hystotype.
An extensive review of the literature reveals about fifty
reports and two important series of pure squamous cell
carcinoma of breast strictly following the Macia et al.
diagnostic criteria [6]: thirty-three patients by M.D.
Anderson Cancer Center and eleven patients reported by
a Spanish group [7,8].
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noma as a tumor with following characteristics [6]:
1. No other neoplastic components, such as ductal or
mesenchymal elements, are present in the tumor.
2. The tumor origin must be independent from the
overlying skin and nipple.
3. Absence of an associated primary squamous cell
carcinoma in a second site.
In this report, we present a patient who initially appeared
with signs and symptoms of mastitis and underwent to
antibiotic therapy without benefit.
Histologic examination of the tissue obtained from
surgery revealed a pure primary squamous cell carcinoma
of the breast.
Case presentation
The patient was a 54-year-old Italian Caucasian female.
She was a non-smoker. She was evaluated in our hospital
for recent onset of pain and tenderness in the left breast.
She referred swelling of the breast, but denied nipple
discharge. Her past medical history was not significant.
Her family history was not significant for breast cancer; she
denied oral contraceptives use in the past and she give
birth to one child. Her most recent Pap smear had been
negative for any squamous lesion. Physical examination
revealed erythema, hyperaemia and tenderness to touch of
the left breast. A palpable well circumscribed and firm
mass measuring about 40 mm was present in the left
inferior lateral quadrant. The right breast examination was
normal. There was no evidence of lymphadenopathy on
physical examination, including the axillary and supracla-
vicular regions.
She underwent an ultrasound examination of the left
breast, which revealed a defined 29 mm mass with a thick
rind and reduced central echogenicity, consistent with a
cystic space. Mammography showed a round, high-density
mass with almost regular but partially irregular margins,
measuring approximately 30 mm.
Fine needle aspiration cytology revealed an infiltrative
poorly differentiated squamous cell carcinoma.
Total body CT scan, bone scan, laboratory data (blood
count, serum electrolytes, liver function tests, creatinine,
prothrombin and partial thromboplastin time), tumors
markers, including the levels of serum carcinoembryonic
antigen, carbohydrate 15-3 and squamous cell carcinoma
antigen were within normal range.
The patient underwent a wide local excision of the left
breast with ipsilateral axillary lymph nodes dissection.
Gross examination revealed a 4.7 cm tumor with central
cystic space located in the center to lower outer quadrant
of the left breast. There were no component of obvious
invasive ductal carcinoma or other features of metaplastic
carcinoma for example spindle cells, or osseous or
cartilaginous metaplasia. It revealed large squamous cells
with keratinizing eosinophilic glassy (Figure 1). The lesion
tends to be differentiated sufficiently to form keratohya-
line granules. The central cystic space contain keratin and
necrotic debris (Figure 2). Vascular or neural invasion was
not identified. There was no involvement of the skin or
skin adenexae of the breast or the nipple. The uninvolved
mammary parenchyma contained fibrocystic changes.
Figure 1. Large Squamous cells with keratinising
eosinophilic glassy. It’s present a modest inflammatory
intralesional reaction (Hematoxylin-Eosin, 20x).
Figure 2. Solid structure with central cystic space
containing keratin and necrotic debris
(Hematoxylin-Eosin, 10x).
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were negative for metastatic disease. Immunohistochem-
ical evaluation was negative for estrogen receptor (ER),
progesterone receptor (PgR) and Her2/neu overexpression
and positive for EGFR. Ki-67 proliferation index was
unfavourably high at 60%.
The patient received an adjuvant therapy based on
5-Fluouracil 600 mg/mq day 1 and Cisplatin (CDDP)
25mg/mqdays1,2,3every3weeksforsixcycles.Afterwards
patient refuse radiation therapy to the residual left breast.
Twenty-eight months after surgery the patient was
asymptomatic and disease free.
Discussion
Pure primary squamous cell carcinoma of the breast is
a rare condition and is considered to arise through
metaplastic change of ductal carcinoma cells [9].
The concept of a disease continuum with varying degrees
of squamous metaplasia was supported by Stevenson et al.
who conclude that SqCC mostly represents an extreme
form of squamous metaplasia within adenocarcinoma [9].
An alternate theory is that arise directly from the
epithelium of the mammary ducts.
The SqCC of the breast are generally large (> 4 cm) at
diagnosis and cystic in 50% of the cases [10].
The prognosis of this type of breast cancer is still regarded
as somewhat controversial, though many studies suggest
that it is an aggressive disease that may behave like poorly
differentiated breast carcinoma [1,5,11].
The breast SqCC is usually a high-grade and hormone
receptor-negative tumor [3]. This means that hormone-
based therapy may not be effective in these tumors.
HER2/neu is also usually not over-expressed or amplified
in this disease [12]. The high frequency of EGFR positivity
is interesting and may be exploited in the development of
future treatments.
Nofindingsonmammographyarespecificforthisdiagnosis
andthismayexplaintheadvanceddiseasestageatdiagnosis
[13]. Breast ultrasound has been reported to be more
helpfulwiththesetumorsappearingassolidhypoechogenic
masses with complex cystic components [14].
The treatment of SqCC of the breast does not differ from
other common histological types of brest cancer and may
involve surgery, chemotherapy, hormonal therapy and
radiation therapy. Because of its rarity the most appropriate
therapeutic regimen for SqCC of the breast is still unclear.
A recent literature review reveals that an average of 70%
of patients with SqCC of the breast do not present axillary
lymph nodes involvement but due the unpredictable
lymph nodes dissemination, axillary lymph nodes dissec-
tion could always be performed for staging purposes [3].
As a result of lack of data, the issue of whether to prescribe
adjuvant treatment for SqCC of the breast, remain
unsolved [3]. A little contribution derived from a review
by M.D. Anderson group of clinical pathologic features,
management andoutcome of SqCC of thebreast inaseries
of 33 patients. Nineteen of the 31 patients with localized
disease received adjuvant chemotherapy and 5 patients
received neoadjuvant chemotherapy. The neoadjuvant
regimens used were antracycline/taxane-based for four
patients and anthracycline-based for one patient. The
tumor did not respond to neoadjuvant chemotherapy in
any patients. No significant difference was seen in relapse
free survival or overall survival rates between the patients
treated with adjuvant (two patients received a regiment
cisplatin based) or neoadjuvant chemotherapy and those
not treated. They conclude that SqCC of the breast is an
extremely aggressive disease and better systemic treatment
is required to prevent recurrence [8].
These findings are in accord with Rostock et al. review
suggests that SqCC is not sensitive to chemotherapeutic
agents commonly used for ductal carcinoma such metho-
trexate, cyclophosphamide, 5-fluorouracil (5-FU) and
antracycline [12]. A good response on metastatic disease
has been reported in one patient who received cisplatin
and 5-fluorouracil but this has never been investigated in
other report [15].
Our patient received adjuvant chemotherapy with 5-
fluorouracil (5-FU) and cisplatin based on other experi-
ences derived from some reports [1,3,4,15].
The role of radiation has been reported as unclear in many
studies. Although squamous cell carcinomas are generally
radiosensitive, locoregional relapse occurred frequently
also in irradiated field. It seems that SqCC of the breast is
often relatively radioresistant [3,4,8,9]. However, consid-
ering the conservative surgery performed, we proposed
radiation therapy but the patient rejected.
Currently twenty-eight months passed from the surgery
without evidence of disease.
Conclusion
Pure Primary Squamous cell carcinoma of the breast is
a very rarely and aggressive disease. Poor response of the
SqCC of the breast to chemotherapeutic regimens com-
monly used in breast cancer, suggests that EGFR inhibitors
and platin based regimens could be a promising option for
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adjuvant therapy was perfectly in accord with the new
suggestions coming from recent literature. Clinical trials
including large series of these rare tumors are needed to
increase our knowledge and to improve patient’s outcome.
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